Nicholas van As

21.9k total citations · 1 hit paper
60 papers, 2.3k citations indexed

About

Nicholas van As is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nicholas van As has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 32 papers in Radiation and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nicholas van As's work include Prostate Cancer Diagnosis and Treatment (43 papers), Prostate Cancer Treatment and Research (34 papers) and Advanced Radiotherapy Techniques (32 papers). Nicholas van As is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (43 papers), Prostate Cancer Treatment and Research (34 papers) and Advanced Radiotherapy Techniques (32 papers). Nicholas van As collaborates with scholars based in United Kingdom, United States and Canada. Nicholas van As's co-authors include Alison Tree, David P. Dearnaley, Vincent Khoo, Robert Huddart, Chris Parker, M. Hawkins, Peter Ostler, Rosalind A. Eeles, Daniel Henderson and Christopher M. Nutting and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and The Lancet Oncology.

In The Last Decade

Nicholas van As

58 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic body radiotherapy for oligometastases

2012 374 citations Alison Tree, Vincent Khoo et al. profile →

Peers

Countries citing papers authored by Nicholas van As

Since Specialization

Citations

This map shows the geographic impact of Nicholas van As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas van As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas van As more than expected).

Fields of papers citing papers by Nicholas van As

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas van As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas van As. The network helps show where Nicholas van As may publish in the future.

Co-authorship network of co-authors of Nicholas van As

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas van As. A scholar is included among the top collaborators of Nicholas van As based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas van As. Nicholas van As is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The contemporary management of prostate cancer 2025 ·CA A Cancer Journal for Clinicians ·(unknown), Peter C. Albertsen, (unknown), Amar U. Kishan, (unknown), (unknown), Angela Pathmanathan, Alison Reid, Oliver Sartor, Nicholas van As, Jochen Walz, Alison Tree	2
2	Dose-response modelling of stereotactic radiosurgery for brain metastases: Preliminary prospective data from the SAFER study (IRAS 276567) 2025 ·Radiotherapy and Oncology ·(unknown), (unknown), Philip Benjamin, (unknown), Julia Henderson, Karen Thomas, (unknown), (unknown), Martin Brewer, Chiara Reverberi, Nicholas van As, (unknown), Francesca Soldà, Liam Welsh, Jeremy Rees, (unknown)	0
3	Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Yae‐Eun Suh, (unknown), (unknown), Daniel Henderson, (unknown), Kirsty Morrison, (unknown), Julia Henderson, (unknown), Aslam Sohaib, (unknown), Alison Tree, Nicholas van As	10
4	Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity 2024 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), Samuel J. Withey, Douglas Brand, (unknown), Andrew Loblaw, Shaun Tolan, Nicholas van As, Alison Tree	3
5	Weekly ultra-hypofractionated radiotherapy in localised prostate cancer 2024 ·Clinical and Translational Radiation Oncology ·Nora Sundahl, Douglas Brand, Chris Parker, David Dearnaley, (unknown), Angela Pathmanathan, (unknown), Nicholas van As, Rosalind A. Eeles, Vincent Khoo, (unknown), Julia Murray	2
6	Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Douglas Brand, Sarah C. Brüningk, Anna Wilkins, Olivia Naismith, Annie Gao, Isabel Syndikus, David P. Dearnaley, Emma Hall, Nicholas van As, Alison Tree, S. Gulliford	1
7	The quantitative impact of prostate-specific membrane antigen (PSMA) PET/CT staging in newly diagnosed metastatic prostate cancer and treatment-decision implications 2023 ·BJR\|Open ·Hassan Abdel‐Aty, (unknown), Iain Murray, (unknown), Nicholas van As, Nicholas D. James	2
8	Single dose prostate radiotherapy — a step too far? 2021 ·Nature Reviews Urology ·Alison Tree, Nicholas van As	1
9	Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Douglas Brand, Sarah C. Brüningk, Anna Wilkins, (unknown), Olivia Naismith, Annie Gao, Isabel Syndikus, David P. Dearnaley, Alison Tree, Nicholas van As, Emma Hall, S. Gulliford	24
10	Patterns of recurrence after prostate bed radiotherapy 2019 ·Radiotherapy and Oncology ·Douglas Brand, (unknown), David P. Dearnaley, Rosalind A. Eeles, Robert Huddart, Vincent Khoo, Julia Murray, Yae‐Eun Suh, Alison Tree, Nicholas van As, Chris Parker	15
11	Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer 2019 ·Current Oncology Reports ·Gargi Kothari, Piet Ost, Patrick Cheung, Pierre Blanchard, Alison Tree, Nicholas van As, Simon S. Lo, Drew Moghanaki, Andrew Loblaw, Shankar Siva	9
12	Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy 2017 ·American Journal of Clinical Nutrition ·Linda Wedlake, Clare Shaw, H. McNair, Amyn Lalji, Kabir Mohammed, (unknown), Lindsey Allan, Diana Tait, M. Hawkins, Navita Somaiah, Susan Lalondrelle, Alexandra Taylor, Nicholas van As, Alexandra Stewart, Sharadah Essapen, Heather Gage, Kevin Whelan, Jervoise Andreyev	52
13	MRI-guided prostate adaptive radiotherapy – A systematic review 2016 ·Radiotherapy and Oncology ·(unknown), (unknown), Lucy Kershaw, (unknown), Linda G.W. Kerkmeijer, C.A. Lawton, Usman Mahmood, Floris J. Pos, Nicholas van As, Marcel van Herk, Danny Vesprini, (unknown), Alison Tree, Ananya Choudhury	117
14	Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21–30 2016 ·European Urology ·Alison Tree, Nicholas van As, David P. Dearnaley	1
15	Prostate Stereotactic Body Radiotherapy — First UK Experience 2014 ·Clinical Oncology ·Alison Tree, (unknown), Peter Hoskin, Pittaya Dankulchai, (unknown), Robert Hughes, (unknown), (unknown), Vincent Khoo, Nicholas van As	27
16	Intensity modulated radiation therapy allows prostate and dose-escalated pelvic radical radiation therapy after renal transplantation 2014 ·Practical Radiation Oncology ·(unknown), Richard Corbett, (unknown), (unknown), Neill Duncan, Vincent Khoo, Nicholas van As	6
17	Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer 2011 ·British Journal of Urology ·Hashim U. Ahmed, Oğuz Akın, Jonathan Coleman, (unknown), Mark Emberton, Larry Goldenberg, Hedvig Hricak, Michael W. Kattan, John Kurhanewicz, Caroline M. Moore, Chris Parker, Thomas J. Polascik, Peter T. Scardino, Nicholas van As, Arnauld Villers, (unknown)	87
18	Prostate‐specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time 2009 ·British Journal of Urology ·Michael Ng, Nicholas van As, Karen Thomas, Ruth Woode‐Amissah, A. Horwich, Robert Huddart, Vincent Khoo, Alan Thompson, David P. Dearnaley, Chris Parker	48
19	A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance 2008 ·European Urology ·Nicholas van As, Nandita M. de Souza, Sophie F. Riches, Veronica A. Morgan, (unknown), David P. Dearnaley, Chris Parker	128
20	Active Surveillance With Selective Radical Treatment for Localized Prostate Cancer 2007 ·The Cancer Journal ·Nicholas van As, Chris Parker	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact